These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7350805)

  • 1. Heroin nephropathy. A clinicopathologic and epidemiologic study.
    Cunningham EE; Brentjens JR; Zielezny MA; Andres GA; Venuto RC
    Am J Med; 1980 Jan; 68(1):47-53. PubMed ID: 7350805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotic syndrome in blacks: histopathologic perspectives.
    Pinn-Wiggins VW
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):49-55. PubMed ID: 3564136
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of heroin abuse on a regional end-stage renal disease program.
    Zielezny MA; Cunningham EE; Venuto RC
    Am J Public Health; 1980 Aug; 70(8):829-31. PubMed ID: 7416344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding spectrum of renal diseases associated with antiphospholipid syndrome.
    Fakhouri F; Noël LH; Zuber J; Beaufils H; Martinez F; Lebon P; Papo T; Chauveau D; Bletry O; Grünfeld JP; Piette JC; Lesavre P
    Am J Kidney Dis; 2003 Jun; 41(6):1205-11. PubMed ID: 12776272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T's and Blues abusers.
    May DC; Helderman JH; Eigenbrodt EH; Silva FG
    Am J Kidney Dis; 1986 Dec; 8(6):404-9. PubMed ID: 3812469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.
    Rao TK; Filippone EJ; Nicastri AD; Landesman SH; Frank E; Chen CK; Friedman EA
    N Engl J Med; 1984 Mar; 310(11):669-73. PubMed ID: 6700641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.
    Okpechi IG; Ameh OI; Bello AK; Ronco P; Swanepoel CR; Kengne AP
    PLoS One; 2016; 11(3):e0152203. PubMed ID: 27011216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q nephropathy: features at presentation and outcome.
    Lau KK; Gaber LW; Delos Santos NM; Wyatt RJ
    Pediatr Nephrol; 2005 Jun; 20(6):744-9. PubMed ID: 15827744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal lesions in sickle cell nephropathy in children.
    Tejani A; Phadke K; Adamson O; Nicastri A; Chen CK; Sen D
    Nephron; 1985; 39(4):352-5. PubMed ID: 3982580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin associated nephropathy: clinical and histological studies in 19 patients.
    Llach F; Descoeudres C; Massry SG
    Clin Nephrol; 1979 Jan; 11(1):7-12. PubMed ID: 428156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephropathy in heroin addicts with staphylococcal septicemia.
    Savin V; Siegel L; Schreiner GE
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():397-408. PubMed ID: 4536434
    [No Abstract]   [Full Text] [Related]  

  • 12. Schistosomal specific nephropathy leading to end-stage renal failure.
    Sobh MA; Moustafa FE; el-Housseini F; Basta MT; Deelder AM; Ghoniem MA
    Kidney Int; 1987 Apr; 31(4):1006-11. PubMed ID: 3108566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent glomerulonephritis after renal transplantation.
    Hamburger J; Crosnier J; Noël LH
    Annu Rev Med; 1978; 29():67-72. PubMed ID: 348049
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA associations in heroin-associated nephropathy.
    Haskell LP; Glicklich D; Senitzer D
    Am J Kidney Dis; 1988 Jul; 12(1):45-50. PubMed ID: 3389354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome and rapid renal failure in autosomal dominant polycystic kidney disease.
    Murphy G; Tzamaloukas AH; Listrom MB; Gibel LJ; Smith SM; Gardner KD
    Am J Nephrol; 1990; 10(1):69-72. PubMed ID: 2343882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of orthostatic proteinuria to focal and segmental glomerulosclerosis.
    Berns JS; McDonald B; Gaudio KM; Siegel NJ
    Clin Pediatr (Phila); 1986 Mar; 25(3):165-6. PubMed ID: 3948459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal glomerular sclerosis.
    Sherman RL; Susin M; Mouradian J
    Perspect Nephrol Hypertens; 1977; 6():175-86. PubMed ID: 320551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the epidemiology of focal segmental glomerulosclerosis.
    Kitiyakara C; Kopp JB; Eggers P
    Semin Nephrol; 2003 Mar; 23(2):172-82. PubMed ID: 12704577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal lesions caused by opiates].
    Caudarella R; Malavolta N; Stefani F
    G Clin Med; 1982 Mar; 63(3):176-84. PubMed ID: 7106466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.